DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Formation of stable submicron peptide or protein particles by thin film freezing

Abstract

The present invention includes compositions and methods for preparing micron-sized or submicron-sized particles by dissolving a water soluble effective ingredient in one or more solvents; spraying or dripping droplets solvent such that the effective ingredient is exposed to a vapor-liquid interface of less than 50, 100, 150, 200, 250, 200, 400 or 500 cm.sup.-1 area/volume to, e.g., increase protein stability; and contacting the droplet with a freezing surface that has a temperature differential of at least 30.degree. C. between the droplet and the surface, wherein the surface freezes the droplet into a thin film with a thickness of less than 500 micrometers and a surface area to volume between 25 to 500 cm.sup.-1.

Inventors:
; ;
Issue Date:
Research Org.:
Board of Regents, The University of Texas System, Austin, TX (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1351888
Patent Number(s):
9622974
Application Number:
14/603,211
Assignee:
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS
Patent Classifications (CPCs):
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
DOE Contract Number:  
FG02-04ER15549
Resource Type:
Patent
Resource Relation:
Patent File Date: 2015 Jan 22
Country of Publication:
United States
Language:
English
Subject:
37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY; 36 MATERIALS SCIENCE

Citation Formats

Johnston, Keith P., Engstrom, Joshua, and Williams, III, Robert O. Formation of stable submicron peptide or protein particles by thin film freezing. United States: N. p., 2017. Web.
Johnston, Keith P., Engstrom, Joshua, & Williams, III, Robert O. Formation of stable submicron peptide or protein particles by thin film freezing. United States.
Johnston, Keith P., Engstrom, Joshua, and Williams, III, Robert O. Tue . "Formation of stable submicron peptide or protein particles by thin film freezing". United States. https://www.osti.gov/servlets/purl/1351888.
@article{osti_1351888,
title = {Formation of stable submicron peptide or protein particles by thin film freezing},
author = {Johnston, Keith P. and Engstrom, Joshua and Williams, III, Robert O.},
abstractNote = {The present invention includes compositions and methods for preparing micron-sized or submicron-sized particles by dissolving a water soluble effective ingredient in one or more solvents; spraying or dripping droplets solvent such that the effective ingredient is exposed to a vapor-liquid interface of less than 50, 100, 150, 200, 250, 200, 400 or 500 cm.sup.-1 area/volume to, e.g., increase protein stability; and contacting the droplet with a freezing surface that has a temperature differential of at least 30.degree. C. between the droplet and the surface, wherein the surface freezes the droplet into a thin film with a thickness of less than 500 micrometers and a surface area to volume between 25 to 500 cm.sup.-1.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue Apr 18 00:00:00 EDT 2017},
month = {Tue Apr 18 00:00:00 EDT 2017}
}

Works referenced in this record:

Cosmetic and pharmaceutical vehicle thickened with solid emulsifier
patent, January 1982


Pseudoplastic gel transfer
patent, May 1986


Highly pseudoplastic polymer solutions
patent, June 1986


Droplet freezing method and apparatus
patent, July 1989


Sustained release, comfort formulation for glaucoma therapy
patent, March 1990


Pharmaceutical composition in gel form in a dispensing package
patent, April 1994


Injectable extended release formulations and methods
patent, October 1994


Use of carrageenans in topical ophthalmic compositions
patent, April 1995


Oral sustained release drug delivery device
patent, April 1996


Viscous suspensions of controlled-release drug particles
patent, July 1996


Method for identifying an oligonucleotide aptamer specific for a target
patent, December 1996


Methods of producing nucleic acid ligands
patent, January 1997


Pharmaceutical formulation
patent, June 1997


Systematic evolution of ligands by exponential enrichment: chimeric selex
patent, June 1997


Protein formulation
patent, July 2001


Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
patent, August 2007


Production of microspheres
patent, May 2008


Nanoclusters for delivery of therapeutics
patent, January 2010


Spherical protein particles and methods for making and using them
patent, August 2011


Low viscosity highly concentrated suspensions
patent, July 2014


Formation of stable submicron peptide or protein particles by thin film freezing
patent, March 2015


Process for production of nanoparticles and microparticles by spray freezing into liquid
patent-application, February 2004


Stable flowable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
patent-application, August 2004


High concentration antibody and protein formulations
patent-application, October 2004


Method for delivering drugs to the brain
patent-application, March 2005


Antibody-containing particles and compositions
patent-application, March 2005


Protein microspheres having injectable properties at high concentrations
patent-application, February 2006


Method to obtain microparticles containing an H+,K+-ATPase inhibitor
patent-application, July 2006


Solvent/polymer solutions as suspension vehicles
patent-application, August 2006


Complexation of metal ions with polypeptides
patent-application, January 2007


Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof
patent-application, July 2007


Protein Microspheres Retaining Pharmacokinetic and Pharmacodynamic Properties
patent-application, September 2007


Use of microparticles combined with submicron oil-in-water emulsions
patent-application, April 2009


Protein nanoparticles
patent-application, July 2009


Compositions and Methods for Drug Delivery
patent-application, November 2009


Protein Nanoparticles and the Use of the Same
patent-application, December 2009


Non-covalent modification of microparticles and process of preparing same
patent-application, January 2010


Methods of Processing Compositions Containing Microparticles
patent-application, February 2010


Protein Formulation
patent-application, June 2010


Lyophilised Antibody Formulation
patent-application, September 2010


Formation of Stable Submicron Peptide or Protein Particles by Thin Film Freezing
patent-application, September 2010


Protein Nanoparticle Dispersions
patent-application, September 2012


Low Viscosity Highly Concentrated Suspensions
patent-application, December 2014


Low Viscosity Concentrated Protein Dispersions
patent-application, March 2016


Commercial challenges of protein drug delivery
journal, January 2005


Advances in ultrarapid freezing for the preservation of cellular ultrastructure
journal, January 1986


Role of calcium phosphate nanoclusters in the control of calcification
journal, April 2009


Concentrated Dispersions of Equilibrium Protein Nanoclusters That Reversibly Dissociate into Active Monomers
journal, January 2012


Reversible Self-Association of a Concentrated Monoclonal Antibody Solution Mediated by Fab–Fab Interaction That Impacts Solution Viscosity
journal, October 2008


Protein Inhalation Powders: Spray Drying vs Spray Freeze Drying
journal, January 1999


Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs
journal, January 2007


Solution-Based Particle Formation of Pharmaceutical Powders by Supercritical or Compressed Fluid Co2 and Cryogenic Spray-Freezing Technologies
journal, January 2001


Spray freezing into liquid versus spray-freeze drying: Influence of atomization on protein aggregation and biological activity
journal, January 2006


Coarse-Grained Strategy for Modeling Protein Stability in Concentrated Solutions
journal, October 2005


Unusual properties of aqueous solutions of l-proline: A molecular dynamics study
journal, November 2005


Anomalously Large Equilibrium Clusters of Colloids
journal, November 2001


Inhibition of protein aggregation in vitro and in vivo by a natural osmoprotectant
journal, August 2006


Enhancement of thermal stability and inhibition of protein aggregation by osmolytic effect of hydroxyproline
journal, January 2007


Theoretical analysis of excipient concentrations during the final ultrafiltration/diafiltration step of therapeutic antibody
journal, July 2009


Thermophysical Properties of Trehalose and Its Concentrated Aqueous Solutions
journal, January 1997


Phase Behavior of Small Attractive Colloidal Particles
journal, January 1996


Coarse-Grained Strategy for Modeling Protein Stability in Concentrated Solutions. II: Phase Behavior
journal, March 2006


Challenges in the development of high protein concentration formulations
journal, June 2004


Protein−solute interactions affect the outcome of ultrafiltration/diafiltration operations
journal, September 2004


Is Random Close Packing of Spheres Well Defined?
journal, March 2000


Molecular Mechanisms of Cryoprotection in Aqueous Proline:  Light Scattering and Molecular Dynamics Simulations
journal, April 2008


Enhancement of Protein Crystal Nucleation by Critical Density Fluctuations
journal, September 1997


The thermodynamic mechanism of protein stabilization by trehalose
journal, February 1997


Structure and thermodynamics of colloidal protein cluster formation: Comparison of square-well and simple dipolar models
journal, September 2009


Macromolecular Crowding and Confinement: Biochemical, Biophysical, and Potential Physiological Consequences
journal, June 2008